A French pharmaceutical affiliate entrusted BlueReg to support them for the whole process of submission (advice, writing activities and support for meeting with the Competent Authorities) of a cohort Temporary Authorisation for Use (cATU) request to the ANSM for a…
A European pharmaceutical company entrusted PharmaBlue (a BlueReg Company) as French «exploitant» with the responsibility of submitting, obtaining and implementing a French Early Access Program called “ATU” (Autorisation Temporaire d’Utilisation) for its orphan drug for patients in nominative and cohort…
A global company recently entrusted to BlueReg the management of pricing and reimbursement activities to bring their product on the French market. Pricing and reimbursement strategy and activities are specific to each country. In France, the positioning of the product…
A big pharmaceutical company entrusted BlueReg (BR) to assist its regulatory team in regulatory activities in SSFSA.
